Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Prescription Drugs Affected by an Expanded Rare Disease Carve-Out from Medicare Price Negotiation
HOME
/
Research Publications
/
Prescription Drugs Affected by an Expanded Rare Disease Carve-Out from Medicare Price Negotiation